Current issues in the epidemiology and toxicology of occupational exposure to lead. by Landrigan, P J
Environmental Health Perspectives
Vol. 89, pp. 61-66, 1990
Current Issues in the Epidemiology
and Toxicology of Occupational
Exposure to Lead
by Philip J. Landrigan*
Occupational exposure to lead is widespread in the United States. Clinically evident lead poisoning as well
as subclinical toxicity occur in populations with occupational lead exposure. The focus of current research
on lead toxicity in industrial populations is in the definition of dose-response relationships, particularly at
low levels ofexposure. Major interest surrounds the development ofbiochemical and physiologic markers of
subclinical toxicity. Need exists to better delineate the toxicity oflead on the peripheral and central nervous
system, the kidneys, the cardiovascular system, and the reproductive organs using newly developed markers
'lb obtain more accurate information on cumulative individual exposure to lead, future research on lead
toxicity will increasingly use X-ray fluorescence analysis for determination of the lead content in bone.
Introduction
Lead is an ancient metal. Its toxicity to industrial workers
has been recognized for millenia. The following verse by
Nikander, a Greek poet and physician ofthe second century
B.C., details the adverse consequences of exposure to
cerussa (lead carbonate); this stanza notes specifically the
occurrence of colic, paralysis, visual disturbance, and enceph-
alopathy in lead workers (1):
The harmful cerussa, that most noxious thing
Which foams like the milk in the earliest spring
With rough force it falls and the pail beneath fills
This fluid astringes and causes grave ills.
The mouth it inflames and makes cold from within
The gums dry and wrinkled, are parch'd like the skin
The rough tongue feels harsher, the neck muscles grip
He soon cannot swallow, foam runs from his lip
A feeble cough tries, it in vain to expel
He belches so much, and his belly does swell
His sluggish eyes sway, then he totters to bed
Phantastic forms flit now in front of his eyes
While deep from his breast there soon issue sad cries
Meanwhile there comes a stuporous chill
His feeble limbs droop and all motion is still
His strength is now spent and unless one soon aids
The sick man descends to the Stygian shades.
Ramazzini, the father of modern occupational medicine,
described industrial lead poisoning in potters and portrait
painters in his classic study de Morbis Artifcum Diatriba
of 1713 (2):
In almost all cities there are other workers who habitually incur
serious maladies from the deadly fumes of metals. Among these are
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the potters ... When they need roasted or calcined lead for glazing
their pots, they grind the lead in marble vessels ... During this
process, their mouths, nostrils, and the whole body take in the lead
poison. ... First their hands become palsied, then they become
paralytic, splenetic, lethargic, and toothless.
I have observed that nearly all the painters whom I know, both in
this and other cities, are sickly. ... For their liability to disease,
there is an immediate cause. I mean the materials of the colors that
they handle and smell constantly, such as red lead (Minium),
cinnabar, and white lead (cerussa).
In Victorian England, Charles Turner Thackrah (3) de-
scribedchronicoccupationalleadpoisoninginplumbers and
white lead manufacturers.
Plumbers are exposed to the volatilized oxide of lead which rises
during the process of casting. Men who are much in this depart-
ment are soon affected with colic and palsy.
The manufacturers of white lead are subjected to its poison both by
the lungs and by the skin. Men soon complain of headache, drowsi-
ness, sickness, vomiting, griping, obstinate constipation, and to
these succeed colic or inflammation of the bowels, disorders of the
urinary organs, and finally, the most marked of the diseases from
lead, palsy. We observed the muscles of the fore-arm, more fre-
quently and sooner to suffer than other parts.
A majorfigure in the more recent history ofoccupational
leadpoisoningin GreatBritain was SirThomas Legge, who
in 1897 was appointed first Medical Inspector ofFactories.
Legge (4) stressedthatindustrialleadpoisoningis due almost
entirelytoinhalation ofleaddustorfume. Heproposedfour
axioms for control of occupational lead poisoning:
1. Unless anduntilthe employerhas done everything-
andeverythingmeans agooddeal-theworkmancan
do next to nothing to protect himself, although he is
naturally willing enough to do his share.P. J. LANDRIGAN
2. If you can bring an influence to bear external to the
workman (i.e. one over which he can exercise no con-
trol) you will be successful; and if you cannot or do
not, you will never be wholly successful.
3. Practically all industrial lead poisoning is due to the
inhalation ofdust andfumes; andifyou stop theirinhal-
ation you will stop the poisoning.
4. All workmen should be told something ofthe danger
ofthe material with which they come into contact and
not be left to find it out for themselves-sometimes
at the cost of their lives.
Under Legge's influence, lead poisoning was made a
reportable disease in Britain in 1899. With the continuing
surveillance and control which followed that order, the
number of reported cases of industrial lead poisoning fell
from 1058 with 38 deaths in 1900 to 505 in 1910, and to
59 in 1973, despite the considerable increase in lead con-
sumption thatoccurred overthat 70-year period. Those data
indicate the importance ofsurveillance and monitoring control
measures for the control of occupational lead poisoning.
Little systematic attention was given to the prevention
ofoccupational leadpoisoning in the United States until Dr.
Alice Hamilton ofHarvard University began her surveys of
occupational lead exposure in 1910 (5). Hamilton observed
that
Only a few years ago, we were most of us under the impression that
our country was practically free from occupational poisoning ... that
our lead works were so much better built and managed, our lead
workers so much better paid, and therefore better fed than the Euro-
pean, that lead poisoning was not a problem here as it is in all other
countries. As a matter of fact, the supposed advantages ... obtained
in only a few of the lead trades and that far from being superior to
Europe in the matter of industrial plumbism, we have a higher rate
in many of our lead industries than have England or Germany.
In recent years, lead poisoning has continued to be dis-
covered with disturbing frequency in the United States (6).
Thus in 1987, in New York, California, and NewJersey, three
states that contain approximately one-fourth ofthe American
workforce, over 1000 workers were found to have blood
lead levels above 40 ,ug/dL; approximately 200 of these
workers had blood lead levels in excess of 50Atg/dL (7-9).
The most severe problems were seen in smelters, foundries,
construction work, demolition, and automobile radiator repair
(10).
This review summarizes recent developments in the
toxicity oflead, particularly in regard to subclinical toxicity.
It discusses areas in which further research is warranted.
Lastly, specific opportunities for undertaking research on
lead toxicity in industrial populations are discussed. It is
important at the outset ofthis discussion to address the con-
cept of subclinical toxicity (11).
Subclinical ¶bxicity
"Subclinical toxicity" denotes the concept that relatively
low-dose exposure to certainchemicals, lead among them,
can cause harmful effects to health that are not evident on
the standard clinical examination. The underlying premise
is that there exists a continuum oftoxicity, in whichclinically
apparent effects have theirasymptomatic, subclinical counter-
parts; these subclinical counterparts have come recently to
be termed "biological markers" oftoxicity (12). Thus, clin-
ically obvious manifestations of lead poisoning such as
anemia, wrist drop, and renal failure lie at the upper end
ofthe range oftoxicity, while such covert effects as slowed
nerve conduction, impairedbiosynthesis ofheme, and altered
excretion of uric acid are their subclinical correlates (13).
Itis important to note that these subclinical changes repre-
sent truly harmful outcomes and are not merely homeostatic
or physiologic adjustments to the presence of lead.
Recognition of the subclinical toxicity of lead has been
made possible by advances in bothlaboratory medicine and
epidemiology. In the laboratory, increasingly sensitive bio-
chemicalandphysiologic probes have beendeveloped. These,
probes canidentify subtle lead-induced injury to such func-
tions as red blood cell enzyme activity, neurologic respon-
siveness, and renal metabolism (14-17). Epidemiologists, for
their part, have mastered the prospective study (18-20).
In a prospective study, a group ofindividuals is followed for-
ward over time. Function is assessed serially, often begin-
ning before first exposure. Each subject serves as his own
control. Unlike a cross-sectional study, in which persons with
various levels ofexposure are compared with one another,
each subject in a prospective study is compared withhimself.
Variation among subjects is thus largely eliminated from the
analysis. Slight decrements in function over time can be
detected with great reliability.
Hematologic Tbxicity
In the red blood cells, anemia is the classic clinical mani-
festation oflead toxicity. The severity and prevalence oflead-
induced anemia are correlated directly with the blood lead
level (21). This anemia results fromtwo mechanisms: impair-
ment of heme biosynthesis and acceleration of red blood
celldestruction. Lead-induced inhibition ofhemebiosynthesis
is due first to inhibition ofthe cytoplasmic enzyme 6 amino-
levulinic acid dehydratase (ALA-D) (22,23). This effect is
dose related. Inhibition ofALA-D is noted initially at blood
lead levels of 10 to 20 Oig/dL and is virtually complete at
levels of 70 to 90 ,tg/dL (24).
The mitochondrial enzyme ferrochelatase is the second
enzyme in the heme biosynthetic pathway inhibited by lead.
Ferrochelatase catalyzes the transfer of iron from ferritin
into protoporphyrin to form heme (25). Inhibition of fer-
rochelatase causes excretion ofcoproporphyrin in the urine
and accumulation ofprotoporphyrin in the erthrocytes (EP).
In adult males, EP levels begin to rise above background
at blood lead levels of 25 to 30 /xg/dL (14). Close correla-
tions have been found between blood lead and EP concen-
trations (26).
Neurologic ¶bxicity
In the peripheral nervous system, the motor axons are
the principaltarget oflead. Lead-induced pathologic changes
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in these fibers include segmental demyelination and axonal
degeneration (27). Extensor muscle palsy with wrist drop
or ankle drop has, since the time of Nikander, been the
classic clinical manifestation of this toxicity (1).
Recent studies of the peripheral nerves in persons
exposed to lead have used electrophysiologic probes to
determine whetherlead causes covert abnormalities in func-
tion. Inthe firstofthese studies, Seppalainen etal. found evi-
dence for asymptomatic slowing ofmotor nerve conduction
velocity in workers whose blood lead levels had never
exceeded 70jLg/dL (28). Araki et al. found similar, asympto-
matic dose-related slowing ofmotor nerve conduction (29).
Following these studies, Seppalainen et al. examined in fur-
ther detail the dose-response relationship between blood
lead levels and conduction velocity (30). They found slowed
conduction in the small motor fibers of the ulnar nerve to
be the most sensitive peripheral index ofthe neurotoxicity
of lead; in a cross-sectional study, ulnar nerve conduction
velocity was depressed at blood lead levels below 50jzg/dL.
Most recently, in a prospective study of new entrants to
the lead industry, Seppalainen et al. found slowing ofulnar
nerve conduction velocity at blood lead levels as low as 30
to 40 jLg/dL (31,32).
In the central nervous system, extensive research has
sought to determine whether lead causes asymptomatic
impairment in function at doses insufficient to produce clinical
encephalopathy. In one of the earliest of these studies,
Hanninen et al. observed a correlation between lead expo-
sure and diminished neuropsychologic performance in 49
asymptomatic workers, all of whom had blood lead levels
below 70 ,tg/dL (33). The functions most severely impaired
were those dependent on visual intelligence and visual-motor
coordination. Similar findings were reported by Valciukas
et al. (34), Arnvig et al. (35), and Araki et al. (36). Baker
etal. reported anincreased prevalence offatigue and short-
term memory loss in smelter workers exposed to lead; the
prevalence ofthose abnormalities increased withbloodlead
levels (21).
Renal Ibxicity
Chronic nephropathy, which may progress to kidney fail-
ure, is the classic renal manifestation of lead toxicity. It
appears to result from long-term, relatively high-dose
exposure to lead.
The cells lining the proximal tubules appear to be the tis-
sue in the kidney most highly sensitive to lead (25). Atblood
leadlevels below 25jxg/dL, lead inhibits the metabolic activa-
tion ofvitamin D, atransformation which takes place inthese
cells (17). Also in these cells, at blood lead levels of 40 to
80 ug/dL, lead induces the formation of dense intranuclear
inclusion bodies consisting of a lead-protein complex (25).
Hyperuremic gout, apparently resulfing from increased reab-
sorption ofuric acidby the tubularcells, is a third metabolic
correlate of lead-induced renal impairment (25).
The evolution of lead nephropathy is usually silent. The
central event appears to be the progressive destruction of
tubular cells and theirreplacement by fibrosis (37). Clinical
manifestations ofimpairment, consisting ofelevations inblood
urea nitrogen (BUN) or serum creatinine, do not ordinarily
become evident until 50 to 75% ofthe nephrons have been
destroyed. Pathologically, the later stage oflead nephropathy
is characterized by interstitial fibrosis with atrophy and
dilation ofthe tubules and relative sparing ofthe glomeruli;
in this stage, intranuclear inclusions are infrequent (25).
Excess mortality from renal disease has been observed
in four epidemiologic studies of lead workers (38-41). In
each ofthese investigations, a 2- to 3-fold increase has been
noted in deaths from chronic nephritis. In the study by
Selevan et al., a positive association was observed between
duration ofemployment in a lead smelter and mortality from
nephritis (41).
Lead and Hypertension
Long-term, high-dose exposure to lead was reportedearly
in this century to be associated with an increased incidence
ofhypertension and cerebrovascular accident (42). With the
reduction in lead exposure that has occurred in most indus-
tries, these associations are now noted less commonly.
Several recent epidemiologic studies have, however, found
evidence that lead absorption, even at relatively low levels,
is associated withsignificant elevationin blood pressure (43).
Toxicologic studies have also documented an association be-
tween increased lead absorption and hypertension (44).
These effects appear to be mediated both through the toxic
effects of lead on the kidneys, as well as by direct action
on vascular smooth muscle.
Reproductive lbxicity of Lead
A body of experimental evidence indicates that lead at
high doses is toxic to reproductive function in both male and
female laboratory animals (45). Also, clinical reports, most
of them from the first half of this century, described
reproductive toxicity in workers of both sexes with high-
dose exposure to lead; the incidence ofspontaneous abor-
tion was reported in these studies to be increased in female
lead workers, as well as in the wives ofmale lead workers
(46,47).
In male workers heavily exposed to lead (mean blood lead
level, 74.5 ug/dL), and also in males with moderately in-
creased lead absorption (mean blood lead level, 52.8/tg/dL),
decreased sperm counts and anincreased prevalence ofmor-
phologically abnormal sperm have been reported (48). Cor-
roboration ofthese findings is providedbytworecent studies,
which also observed sperm count depression at relatively
high blood lead levels (> 60 jig/dL) (49,50).
A most difficult problem in regard to the reproductive tox-
icity of lead is raised by the recently reported finding that
lead causes neurologic damage to the fetus at blood lead
levels as low as 15 to 20 Atg/dL-levels substantially below
current workplace exposure standards. This finding has been
noted in three separate prospective studies and appears
highly credible (18-20). Lead passes virtually unimpeded
across the placenta, and the neurologic impairment that it
produces in the fetus appears to be irreversible.
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Research Needs in Occupational
Lead Toxicity
The focus ofcurrent research onlead toxicity inindustrially
exposed populations is onbetter delineation ofdose-response
relationships, particularly at low levels of exposure. Intense
interest surrounds the development of biochemical and
physiologic markers of both lead exposure and subclinical
toxic effects. Use ofsuch markers in clinical and epidemio-
logic studies holds great promise for improving understand-
ing of the toxicity of lead at relatively exposure levels.
Peripheral Nervous System
To determine the subclinical toxic effects of lead on the
peripheral nervous system in industrial workers, particularly
at low levels of exposure, additional prospective studies will
be required. These studies will examine dose-response rela-
tionships in further detail, identify any thresholds oftoxicity,
and determine which specific measures undertaken in which
subsets of nerve fibers will provide the most sensitive and
specific information on subclinical peripheral neurotoxicity.
The most successful of these studies will almost certainly
employ a prospective, longitudinal design focusing on new
entrants to the lead industry, an approach similar to that
used by Seppalainen et al. (32). A further methodologic
advance that should be considered in such studies is the
use of repeated, nonpainful evaluations of peripheral
neurologic function, such as evaluations of temperature or
vibration threshold, as has been described by Letz and Baker
(15).
Central Nervous System
Additional studies to better define dose-response relation-
ships between lead absorption and subclinical impairment
of the central nervous system in adult workers are also
required. The issue ofsubclinical central neurologic toxicity
is not nearly so well defined in adults as it is in children,
and prospective epidemiologic studies ofcentral neurologic
toxicity have not yet been undertaken in populations oflead
workers (18-20). Industrial populations are an ideal group
in which to undertake such evaluations, because they are
carefully defined and receive periodic blood lead and air lead
monitoring. Again, the most successful design will likely con-
sist of prospective studies of new entrants to the industry
using state-of-the-art neuropsychologic probes. As an interim
measure, cross-sectional studies employing these probes
will also be most useful.
An unexplored implication of the observation that lead
causes insidious, asymptomatic injury to the central ner-
vous system is that some fraction of cases of dementia or
other late-onset neurologic illness may result from chronic
exposure to lead. Case-control epidemiologic studies to
assess chronic lead exposure in persons with chronic neuro-
logical disease are needed to assess this troubling possibility.
Renal Toxicity
The most important research need in the study of lead
nephropathy is a reliable early biological indicator of the
kidney damage induced by lead (37). Such a marker would
permit better assessment of dose-response relationships
and might enable determination of the proportion of cases
of renal failure caused by chronic exposure to lead.
Another need in epidemiologic studies of renal disease
in lead workers is a sensitive, reliable measure of chronic
exposure to lead. The blood lead determination, because
it reflects only relatively recent exposure, provides only
limited information for assessment ofdose-response relation-
ships in regard to chronic toxic effects, such as lead
nephropathy. For evaluation of these effects a marker of
chronic absorption is needed. A most promising approach
to development of such a measure is offered by X-ray
fluorescence analysis, a technology that permits rapid, non-
invasive assessment of the lead burden in bone (51-53).
Application ofthis technology in epidemiologic studies which
also use newly developed biological markers of subclinical
impairment offers the possibility of reliable early detection
of lead-induced nephropathy in lead workers who are not
yet clinically impaired.
Cardiovascular ¶bxicity
Further elucidation ofthe dose-response relationship be-
tween lead and hypertension and assessment ofits clinical
importance will also require the use in population studies
ofan integrated measure ofchronic lead absorption. Again,
the most promising approach to this measure appears to
be noninvasive X-ray fluorescence analysis of lead in bone
(51,53).
Reproductive Tbxicity
Further research will be required to delineate dose-
response relationships in males for the reproductive toxicity
of lead. In particular, there is need to determine whether
the toxic effects of lead on male reproductive function are
demonstrable at blood lead levels below 60 Itg/dL. Such
research will need to examine not only testicular function,
but also will need to consider the possible toxic effects of
lead on the entire gonado-hypothalamic-pituitary axis (6).
This research will help to determine whether men are as
susceptible to the toxic effects of lead on reproduction at
low levels of exposure as are pregnant women.
Concluding Comments
It is important to recognize that in addition to research,
better control ofoccupational exposure to lead in the work-
place is required in the United States. The present situa-
tion, in which clinically evident lead poisoning continues to
occur in industrial workers (6-10) and in which subclinical
lead toxicity is not prevented by currentworkplace exposure
standards or biologic limit values, constitutes a regulatory
crisis (54). Resolution of this crisis will require improved
enforcement ofexisting regulations. Additionally, enactment
of new, more stringent regulations will almost certainly be
necessary to prevent the toxic effects oflead that currently
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are occurring in workers at exposure levels below legally
mandated thresholds (54). These new regulations will need
to contain specific provisions reducing permissible levels of
occupational exposure to lead in air and for reducing the
acceptable biological limit value forlead in blood. Additionally,
protection ofthe fetus will likely require enactment ofspecial
provisions for the medical removal protection of reproduc-
tivity active, non-contracepting women; in the best of cir-
cumstances, these provisions will be coupled with provi-
sions for retention of pay grade over specified intervals of
time (54).
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